Dudediligence.

Stoke Therapeutics, Inc

STOKNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 3013GPassive stake of 5% or more (13G), filed by Biotechnology Value Fund L P
  2. Sep 258-KOfficer or director change5.02
  3. Aug 38-KOther events8.019.01
  4. Aug 3424B5Prospectus for an offering
  5. Aug 310-QQuarterly report
  6. Aug 38-KResults of operations2.029.01
  7. Jun 308-KRegulation FD disclosure and other events7.018.019.01
  8. Jun 48-KShareholder vote5.07
  9. May 78-KResults of operations2.029.01
  10. May 710-QQuarterly report
  11. Apr 78-KOfficer or director change and Regulation FD disclosure5.027.019.01
  12. Mar 278-KChange of auditor4.019.01
  13. Mar 1610-KAnnual report
  14. Mar 38-KOfficer or director change5.02
  15. Jan 268-KMaterial agreement and new debt or obligation1.012.03
  16. Jan 128-KResults of operations and Regulation FD disclosure2.027.018.019.01
  17. Dec 5, 20258-KRegulation FD disclosure and other events7.018.019.01
  18. Nov 4, 202510-QQuarterly report
  19. Nov 4, 20258-KResults of operations2.029.01
  20. Oct 6, 20258-KOfficer or director change5.029.01
  21. Sep 18, 20258-K/AShareholder vote (amended)5.07